stocks logo

MLAB Valuation

Mesa Laboratories Inc
$
116.750
-1.800(-1.520%)
  • Overview
  • Forecast
  • Valuation

MLAB Relative Valuation

MLAB's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, MLAB is overvalued; if below, it's undervalued.

Historical Valuation

No Data

Competitors Valuation Multiple

The average P/S ratio for MLAB's competitors is 4.81, providing a benchmark for relative valuation. Mesa Laboratories Inc Corp (MLAB) exhibits a P/S ratio of 2.67, which is -44.45% above the industry average. Given its robust revenue growth of 17.52%, this premium appears unsustainable.

FAQ

arrow icon

Is Mesa Laboratories Inc (MLAB) currently overvalued or undervalued?

Mesa Laboratories Inc (MLAB) is now in the Undervalued zone, suggesting that its current forward PE ratio of 16.63 is considered Undervalued compared with the five-year average of 31.86. The fair price of Mesa Laboratories Inc (MLAB) is between 152.39 to 319.13 according to relative valuation methord. Compared to the current price of 116.75 USD , Mesa Laboratories Inc is Undervalued By 23.39% .
arrow icon

What is Mesa Laboratories Inc (MLAB) fair value?

arrow icon

How does MLAB's valuation metrics compare to the industry average?

arrow icon

What is the current P/B ratio for Mesa Laboratories Inc (MLAB) as of May 20 2025?

arrow icon

What is the current FCF Yield for Mesa Laboratories Inc (MLAB) as of May 20 2025?

arrow icon

What is the current Forward P/E ratio for Mesa Laboratories Inc (MLAB) as of May 20 2025?

arrow icon

What is the current Forward P/S ratio for Mesa Laboratories Inc (MLAB) as of May 20 2025?